Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2016, Vol. 43 Issue (1): 109-111    DOI: 10.12891/ceog3157.2016
Case Report Previous articles | Next articles
Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine
J.H. Check1, 2, *()
1Cooper Medical School of Rowen University Department of Obstetrics and Gynecology Division of Reproductive Endocrinology and Infertility, Camden, NJ
2Cooper Institute for Reproductive Hormone Disorders, Mt. Laurel, NJ (USA)
Download:  PDF(57KB)  ( 12 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To describe a cause and treatment for chronic unremitting lower abdominal pain of long duration with unknown origin. Materials and Methods: A 50-year-old woman with 30 years of unexplained right lower quadrant pain was treated with dextroamphetamine sulfate. Results: Dramatic complete abrogation of the pain occurred within two weeks. The complete relief persisted for two years while she remains on therapy. Conclusions: Symphathetic neural hyperalgesia edema syndrome should be considered whenever there is refractory pelvic or abdominal pain.
Key words:  Lower abdominal pain      Sympathetic neural hyperalgesia edema syndrome      Sympathomimetic amines      Dextroamphetamine sulfate     
Published:  10 February 2016     
*Corresponding Author(s):  J.H. CHECK     E-mail:  laurie@ccivf.com

Cite this article: 

J.H. Check. Chronic unremitting lower abdominal pain quickly abrogated following treatment with amphetamine. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 109-111.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3157.2016     OR     https://ceog.imrpress.com/EN/Y2016/V43/I1/109

[1] J.H. Check, D. Check, R. Cohen. A novel effective treatment for menière’s disease – dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 807-809.
[2] J.H. Check, D. Check. The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 812-814.
[3] J.H. Check, R. Cohen. Sympathomimetic amine therapy abrogates severe long-term unexpalined abdominal pain and diarrhea (microscopic colitis) - possible infertility implications[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 489-491.
[4] J.H. Check, D.L. Check, M.P. Dougherty. Marked improvement of the aromatase induced arthralgia syndrome following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 291-292.
[5] J.H. Check, M.P. Dougherty. Use of sympathomimetic amines to correct premenstrual urticaria and anaphylaxis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 309-312.
[6] J.H. Check, M.P. Dougherty, D.L. Check. Long standing post-herpetic neuralgia resistant to standard anti-neuropathy medication showing quick dramatic improvement following treatment with sympathomimetic amines[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 335-336.
[7] J.H. Check, M. Citerone, T. Citerone. The increased cellular permeability syndrome as a cause of traumatic stuttering[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 773-774.
[8] J.H. Check. Changing the name of a syndrome: sympathetic neural hyperalgesia edema syndrome becomes – the increased cellular permeability syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 819-823.
[9] J.H. Check, R. Cohen. Amelioration of severe generalized idiopathic pruritus in an estrogen deficient woman taking an aromatase inhibitor for breast cancer following treatment with amphetamine salts[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 934-935.
[10] J. H. Check, R. Cohen. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 611-612.
[11] J.H. Check, A. Jaffe. Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 272-274.
[12] J.H. Check. Sympathetic neural hyperalgesia edema syndrome as a cause of autoimmune hearing loss[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 133-134.
[13] J.H. Check. Increased tissue permeability and sympathetic nervous system hypofunction may be the common link between dysmenorrhea, chronic pelvic pain, Mittelschmerz, and Crohn’s disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 112-113.
[14] J.H. Check. Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome - a case that emphasizes the role of the gynecologist in treating headaches in women[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 119-122.
[15] J.H. Check, A. Jaffe. Resolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 671-672.
No Suggested Reading articles found!